explore -WSS

explore

author：entertainment 2025-09-05 09:11:41 - browse：474

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： ACIP vaccine advisory panel sees its vacancies filled

Wikipedia

explore

WSS

Former New York Mayor de Blasio and wife announce separation, but not divorce

Congress considering partial increase for doctor pay in Medicare

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Princess Kate attends Wimbledon with Roger Federer: See the photos

Too many hospitalized Covid

hotspot

explore

hotspot

How to save PrEP access — and even expand it

Here’s what’s in the FDA plan to include pregnant women in clinical trials

In Memoriam: Notable people who died in 2023

5 shark bites reported on Long Island as officials deploy surveillance drones

Activists slam private health insurers over coverage restrictions

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Bright Health sells Medicare Advantage business to Molina

Why don't Americans have at

entertainment

Condition critical? Britain's beloved but battered National Health Service turns 75

Juul documents reveal insider tactics on political lobbying

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Ebola vaccine can save some who are already sick, per new study

Juul documents reveal insider tactics on political lobbying

Wikipedia

entertainment

explore

knowledge